Td Asset Management Inc Gilead Sciences, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 779,446 shares of GILD stock, worth $71.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
779,446
Previous 727,157 7.19%
Holding current value
$71.6 Million
Previous $49.9 Million 30.95%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$66.59 - $83.99 $3.48 Million - $4.39 Million
52,289 Added 7.19%
779,446 $65.3 Million
Q2 2024

Aug 02, 2024
SELL
$63.15 - $72.88 $20.7 Million - $23.9 Million
-328,023 Reduced 31.09%
727,157 $49.9 Million
Q1 2024

May 08, 2024
BUY
$71.58 - $87.29 $1.83 Million - $2.23 Million
25,523 Added 2.48%
1,055,180 $77.3 Million
Q4 2023

Feb 12, 2024
BUY
$73.27 - $83.09 $18.8 Million - $21.3 Million
256,039 Added 33.1%
1,029,657 $83.4 Million
Q3 2023

Oct 27, 2023
SELL
$73.94 - $80.67 $8.72 Million - $9.52 Million
-118,000 Reduced 13.23%
773,618 $58 Million
Q2 2023

Aug 09, 2023
SELL
$76.01 - $86.7 $7.73 Million - $8.81 Million
-101,640 Reduced 10.23%
891,618 $68.7 Million
Q1 2023

May 10, 2023
SELL
$77.31 - $88.08 $660,536 - $752,555
-8,544 Reduced 0.85%
993,258 $82.4 Million
Q4 2022

Feb 06, 2023
SELL
$62.32 - $89.47 $1.83 Million - $2.62 Million
-29,329 Reduced 2.84%
1,001,802 $86 Million
Q3 2022

Nov 07, 2022
BUY
$59.54 - $68.01 $607,784 - $694,246
10,208 Added 1.0%
1,031,131 $65 Million
Q2 2022

Aug 04, 2022
BUY
$57.72 - $65.01 $5.01 Million - $5.64 Million
86,772 Added 9.29%
1,020,923 $63.1 Million
Q1 2022

May 10, 2022
BUY
$57.92 - $72.58 $3.44 Million - $4.31 Million
59,414 Added 6.79%
934,151 $55.5 Million
Q4 2021

Feb 10, 2022
BUY
$64.88 - $73.64 $209,043 - $237,268
3,222 Added 0.37%
874,737 $63.5 Million
Q3 2021

Nov 09, 2021
BUY
$67.69 - $73.03 $359,704 - $388,081
5,314 Added 0.61%
871,515 $60.9 Million
Q2 2021

Aug 11, 2021
BUY
$63.47 - $69.35 $7.3 Million - $7.98 Million
115,024 Added 15.31%
866,201 $59.2 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $12.8 Million - $14.6 Million
213,988 Added 39.83%
751,177 $48.5 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $1.89 Million - $2.16 Million
33,449 Added 6.64%
537,189 $31.3 Million
Q3 2020

Nov 10, 2020
BUY
$62.1 - $78.08 $7.92 Million - $9.96 Million
127,610 Added 33.93%
503,740 $31.8 Million
Q2 2020

Aug 13, 2020
SELL
$72.34 - $84.0 $535,460 - $621,768
-7,402 Reduced 1.93%
376,130 $28.9 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $1.02 Million - $1.31 Million
-16,283 Reduced 4.07%
383,532 $28.7 Million
Q4 2019

Feb 11, 2020
SELL
$61.62 - $67.78 $2.27 Million - $2.5 Million
-36,836 Reduced 8.44%
399,815 $26 Million
Q3 2019

Nov 07, 2019
SELL
$62.51 - $69.0 $1.58 Million - $1.75 Million
-25,349 Reduced 5.49%
436,651 $27.7 Million
Q2 2019

Aug 01, 2019
SELL
$61.87 - $69.38 $768,920 - $862,254
-12,428 Reduced 2.62%
462,000 $31.2 Million
Q1 2019

May 08, 2019
SELL
$62.53 - $70.05 $4.17 Million - $4.67 Million
-66,702 Reduced 12.33%
474,428 $30.8 Million
Q4 2018

Feb 01, 2019
SELL
$60.54 - $79.0 $82,576 - $107,756
-1,364 Reduced 0.25%
541,130 $33.8 Million
Q3 2018

Nov 01, 2018
SELL
$71.28 - $78.92 $1.29 Million - $1.43 Million
-18,122 Reduced 3.23%
542,494 $41.9 Million
Q2 2018

Jul 31, 2018
SELL
$64.88 - $75.68 $28.4 Million - $33.1 Million
-436,963 Reduced 43.8%
560,616 $39.7 Million
Q1 2018

May 11, 2018
SELL
$72.84 - $88.8 $3.16 Million - $3.85 Million
-43,349 Reduced 4.16%
997,579 $75.2 Million
Q4 2017

Feb 02, 2018
SELL
$71.15 - $83.52 $524,873 - $616,127
-7,377 Reduced 0.7%
1,040,928 $74.6 Million
Q3 2017

Nov 09, 2017
BUY
$72.11 - $85.47 $75.6 Million - $89.6 Million
1,048,305
1,048,305 $84.9 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email